Beam
Beam Therapeutics
BEAM biotech USA
Quick answer
Beam is a biotech company (BEAM) headquartered in CAMBRIDGE, MA, USA with 9 tracked pipeline programs.
Pipeline (9)
project
BEAM-101
Sickle Cell Disease
1 trials projectBEAM-201
Lymphoblastic Lymphoma
1 trials projectBEAM-301: Single dose of BEAM-301 administered by IV
Glycogen Storage Disease Type Ia
1 trials projectBEAM-302
Alpha 1-Antitrypsin Deficiency
1 trials projectAllogeneic anti-CD7 CAR-T cells (BEAM-201)
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
1 trials projectBEAM-103
Healthy Subjects
1 trials projectBEAM Dream Powder
Sleep
1 trials projectBeam Organics Dream Powder
Sleep
1 trials projectPRDR
Glioma
1 trialsDrugs (3)
Patents (8)
patent
US 12296053
Nanomaterials comprising triols
patentUS 12268753
Nanomaterials comprising a biodegradable feature
patentUS 12133884
Methods of substituting pathogenic amino acids using programmable base editor sy
patentUS 12059477
Nanomaterials
patentUS 12016908
Compositions and methods for treating hemoglobinopathies
patentUS 11795443
Uses of adenosine base editors
patentUS 11752202
Compositions and methods for treating hemoglobinopathies
patentUS 11594345
Method for producing Ac-225 from Ra-226